SCHEMBL31163124

SCHEMBL31163124

CC(=O)c1ccc(Nc2ncc(C)c(Nc3cccc(S(=O)(=O)NC(C)(C)C)c3)n2)cc1

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BRD4 O60885 11/20 0.74
▸ JAK1 P23458 8/20 0.74
▸ HDAC1 Q13547 6/20 0.74
▸ JAK2 O60674 7/20 0.71
▸ JAK3 P52333 5/20 0.68
▸ RET P07949 3/20 0.68
▸ WEE1 P30291 3/20 0.68
▸ FLT3 P36888 3/20 0.68
▸ ALK Q9UM73 3/20 0.68
▸ BRDT Q58F21 2/20 0.68
▸ BUB1B O60566 1/20 0.68
▸ BRD2 P25440 1/20 0.68
▸ BRD3 Q15059 1/20 0.68
▸ TYK2 P29597 4/20 0.66
▸ HDAC3 O15379 2/20 0.66
▸ HDAC4 P56524 2/20 0.66
▸ HDAC7 Q8WUI4 2/20 0.66
▸ HDAC2 Q92769 2/20 0.66
▸ HDAC10 Q969S8 2/20 0.66
▸ HDAC11 Q96DB2 2/20 0.66

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30565222 0.93 BRD4 (0.74) BRD4JAK1HDAC1JAK2JAK3
SCHEMBL25382552 0.93 BRD4 (0.74) BRD4JAK1HDAC1JAK2JAK3
SCHEMBL30565200 0.91 JAK1 (0.81) BRD4JAK1HDAC1JAK2JAK3
SCHEMBL25383521 0.91 JAK1 (0.81) BRD4JAK1HDAC1JAK2JAK3
SCHEMBL28657345 0.91 BRD4 (0.77) BRD4JAK1HDAC1JAK2JAK3
SCHEMBL25382998 0.90 BRD4 (0.74) BRD4JAK1HDAC1JAK2JAK3
SCHEMBL30565206 0.90 BRD4 (0.74) BRD4JAK1HDAC1JAK2JAK3
SCHEMBL30565204 0.90 BRD4 (0.74) BRD4JAK1HDAC1JAK2JAK3
SCHEMBL13031046 0.89 BRD4 (0.74) BRD4JAK1HDAC1JAK2JAK3
SCHEMBL13031088 0.89 BRD4 (0.73) BRD4JAK1HDAC1JAK2JAK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4673149-A1 NEW COMPOUNDS AND TREATMENT OF RENAL CELL CARCINOMA Trustlife Global Inc. (US) 2026-01-07 — — EP disclosed
WO-2024179699-A1 NEW COMPOUNDS AND TREATMENT OF RENAL CELL CARCINOMA BASH BIOTECH INC. (US) 2024-09-06 — — WO disclosed
Send feedback